Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Abbott researchers discover series of histone deacetylase inhibitors

July 29, 2002

Marshall Edwards and NIDCR to study phenoxodiol

July 29, 2002

Merck describes basic research in the area of tyrosine kinase inhibitors

July 26, 2002

Aromatase inhibitor from Yamanouchi withdrawn from development

July 26, 2002

Eligard 22.5 mg approved for advanced prostate cancer

July 25, 2002

New FTase inhibitors in early development at Schering-Plough

July 25, 2002

VE-cadherin antibody for cancer and other disorders associated with angiogenesis

July 25, 2002

New CDK inhibitors identified at BMS

July 24, 2002

AstraZeneca patent describes MEK inhibitors for use in cancer

July 23, 2002

Phase II Aroplatin trial enrolling in metastatic colorectal cancer

July 22, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...